Bone Marrow Transplant

Research

Clinical Protocols at UCSF Adult Hematology and Bone Marrow Transplantation Program

Bone Marrow and Stem Cell Transplantation

• A pilot study of umbilical cord blood transplantation in adult patients with advanced hematopoietic malignancies. (CC# 02253)

• A dose-finding study of the drugs, Gemtuzumab Ozogamicin (Mylotarg) combined with Melphalan and Fludarabine as preparative therapy for allogeneic transplantation in older or medically ill patients with acute myelogenous leukemia, chronic myelogenous leukemia or high-risk myelodysplastic syndrome. (CC# 02256)

• A study of autologous stem cell transplantation for acute myeloid leukemia in patients experiencing a first remission of their condition. (Protocol 9302)

• A phase II study of adoptive immunotherapy by allogeneic stem cell transplantation for the treatment of metastatic renal cell carcinoma. (CALGB 90003)

• A pilot study evaluating the drugs, Busulfan and Fludarabine as preparative therapy in adults with hematopoietic disorders who are undergoing a matched unrelated donor stem cell transplantation. (CC# 02257)

• A study of mini-allogeneic stem cell transplantation with matched unrelated donors for the treatment of hematologic malignancies. (CC# 01251)

• A study of non-myeloablative allogeneic hematopoietic cell transplantation for patients with disease relapse or myelodysplasia after they have undergone a previous autologous transplantation. (CALGB 100002)

• A study of minimal ablation and cellular immune therapy of chronic lymphocytic leukemia, prolymphocytic leukemia, low-grade Non-Hodgkin's lymphoma and mantle cell lymphoma with allogeneic donor stem cells. (CALGB 109901)

• A study of nonmyeloablative allogeneic bone marrow transplantation for patients with high-risk indolent hematologic malignancies. (CC# 98251)

Reviewed by health care specialists at UCSF Medical Center.
Last updated May 8, 2007